INTRODUCTION
Parinamashoola is one common clinical problem of our day to day practice, it is very well described in ayurvedic texts of latter periods. On analizing it in modern light, its description is very much similar to peptic ulcer disease and which is well known established entity.
Its incidence is increasing rapidly day by day, since last few decades, most appropriate explanation for this, may be due to more stresses and strain in today's life because of rapid urbanization and mordenistion. It commonly affects 5-10% of people, at any stage of their life.
Introduction of endoscopy in the field of medicine, revolutionized the diagnosis of peptic ulcer and also differentiated from other similar disease (like Non Ulcer dyspepsia).
The study and use of crude drugs is one of the oldest of medical sciences. Cruds drugs have always constituted more than half of the remedial agents in use at any time (Ferguson 1958) . A number of drugs are available for treatment of peptic ulcer disease, including non ulcer dyspepsia. These are not easily available to all the patients, due the their high cost and some of them can not be used due to certain side effects also permanent cure of this disease is not possible yet, because of tits nature of recurrence.
Various drugs are also described in Ayurvedic texts, for management of Parinamashoola.
These are being commonly used by Ayurvedic clinician, since long time. Dhatrilauha, is very popular herbominerla compound (drug) and described for management of Parinamashoola.
In the present clinical study, Dhatrilauha is taken into account, to see, its effect I patients of Parinamashoola, on the basis of scientific parameters. Effect of Dhatrilauha was also compared with ranitidine, a modern drug.
MATERIALS AND METHODS
The present clinical stud was conducted in uncomplicated cases of Parinamashoola. Selection of patients was done randomly from Kayachikitsa (O.P.D and I.P.D) and gastroenterology, O.P.D., S.S. Hospital, B.H.U., Varanasi. Cases for this study were selected during the September 1991 to November 1992.
The detailed symptomatic case history, demographic profile was recorded according to proforma prepared.
After clinical examination, they were subjected to necessary modern laboratory, radiological (Barium contrast examination) and endoscopic examination, then diagnosis was confirmed and trial drug was given.
In this study total number of 30 cases were taken and they were divided into two groups:
This group was comprised of 20 patients. Out of 20 cases, there were 5 cases of peptic ulcer (Gastric or duodenal) and 15 cases of Non ulcer dyspepsia, having no peptic ulcer dyspepsia, having no peptic ulcer like finding on radiological and endoscopic examination, all of these patients were subjected to trial drug, Dhatrilauha, in the dose of 1gm x 3, divided doses per day. The duration of treatment was kept 6 weeks.
(b) Group 'B'
This group was comprised of 3 cases of peptic ulcer and 7 cases of Non-ulcerdyspepsia. Thus total numbe5 of cases was 10. All these patients were kept on ranitidine, 150 mg x b.d. for six weeks.
Clinical Profile
The symptom and sign were graded, on a 0,1,2,3 scale, for statistical valuation as follows: 0-Absent 2-Moderate 1-Mild 3-Severe Grading of common symptoma tology was done in above manners.
Drug
Dhatrilauha is very popular herbomineral compound. It is being used in the cases of parinamashoola since ears. In the present clinical stud, this compound drug is taken, to see the efficacy of this drug is taken, to see the efficacy of this drug in t patients of parinamashoola. The drug was prepared in Ayurvedic pharmacy, I.M.S., B.H.U., Its constituents are:
The dose of drug was given in this clinical study, 1 gm in 3 divided doses per day with honey. The duration was kept 6 weeks.
Parameters of Assessment of Result
The effect of Dhatrilauha was compared with modern drug ranitidine. The following parameters were adopted for the assessment of response and its comparison. In the cases of non ulcer dyspepsia, there was no ulcer like finding, but there was presence of reflex oesophagitis, gastritis (antral or fundal), duodenitis or deformed pylorus and duodenal bulb. In these cases assessment was done on the basis of reduction or absence of above lesion.
Criteria of response of Drug
The result of drug was assessed n the basis of clinical symptomatology and improvement in radiological and endoscopic findings:
1. Excellent 2. Good 3. Poor 4. Unchanged
RESULTS
A total number of 30 patients of Parinamashoola are included in this study. The relevant data in respect of demographic and clinical profile were recorded and in each case evaluated. Some of the observations are exhibited in following tales. Demographic and clinical profile was recorded with a view to define the type of patients selected for present study. 
Radiological and Endoscopic Examination
In the present clinical stud, each and every case of parinamashoola, i.e. diagnosed on clinical examination (symptomatic basis), is further subjected to radiological examination (Barium meal examination) and endoscopic examination for stomach and duodenum. Cases having positive findings of peptic ulcer were kept in peptic ulcer were kept in peptic ulcer group.
Some of them having no positive findings of peptic ulcer, these cases were kept in non ulcer dyspepsia group. Despite the positive radiological findings, only endoscopic confirmation of peptic ulcer was considered as of final criteria for diagnosis.
The study reveals that, most commonly observed radiological findings in cases of Non Ulcer Dyspepsia are deformity of pylorus and duodenal bulb. In same cases, this is also accompanied by surrounding oedematous appearance. Before the introduction of endoscopy, marked deformity and irregularity of duodenal bulb was considered due to peptic ulcer, On endoscopic examination these cases showed findings like oesophagitis, gastritis (antral/ fundla) or duodenitis. Positive findings of peptic ulcer were absent. Some cases also showed normal radiological and endoscopic findings.
Cases of peptic ulcer group showed radiological findings of peptic ulcer, like ulcer crater I lesser curvature or I part of duodenum and irregular, deformed and oedematous pylorus or duodenal bulb. The endoscopic examination revealed positive findings of peptic ulcer (maximum of duodenal ulcer in this study) in all the cases.
Response of treatment
Response of treatment of non Ulcer Dyspepsia (diagnose on radiological and edoscopic examination criteria) cases assessed on the symptomatic improvement. And Peptic Ulcer cases assessed on clinical, radiological and endoscopic improvement.
(a) Clinical Improvement
The following observations have been made form the response of treatment on reduction of mean symptoms score (Table VII) . Regarding pain in abdomen reduction of mean score is 1.33 ± 0.23 in Non Ulcer Dyspepsia, whereas in control group 1.857 ± 0.26. The peptic ulcer group as shown mean reduction of 1.4 ± 0.25 in trial group, whereas in control group it was 1.67 ± 0.33. It is evident that relief of pain in abdomen was statistically significant in all groups on Non Ulcer Dyspepsia and peptic ulcer, but comparatively more significant in control group.
The response of acid eructation with the trial drug was highly significant (p< 0.001) in the Non Ulcer Dyspepsia and peptic ulcer and in the control group it was significant in peptic ulcer, but comparatively less in Non Ulcer Dyspepsia cases.
The clinical symptom vomiting was responded well in Non Ulcer Dyspepsia cases of trial group (p< 0.001), than control group (p<0.05). Whereas in peptic ulcer the symptom ad not sown any significant improvement (p< 0.05).
The another symptom, heartburn was responded well in Non Ulcer Dyspepsia and peptic ulcer cases of both trial and control groups, but statistically highly significant response was seen in Non Ulcer Dyspepsia cases of trial group.
Mild to moderate response was observed in symptom belching by the trial dug, whereas in control group the response was insignificant statistically. 
This was assessed in all the cases of peptic ulcer by repeat barium meal examination, in both trial and control group (Table IX) The present study sows tat, there is mixed response obtained in radiological improvement, in both the groups. It may be due to that it required stud of long term duration. 
Table IX

(C)Endoscopic Improvement
This was assessed in all the cases of peptic ulcer repeat endoscopic examination to see the effect on trial and control group (Table  X) There is significant improvement in endoscopic findings in both trial and control group, despite the persistant radiological findings in some cases.
It is not significant to calculate percentage of improvement in radiological and endoscopic findings, due to less number of case in peptic ulcer group.
Discussion
By considering the efficacy of Dhatri-lauha, it was decided to perform a study on scientific parameters and evaluate the efficacy of drug in parinamashoola, as, it has been already said tat clinical description of parinamashoola was gradually evolved in altter texts first of all, by madhavkar and further scientific input was added by vijayarakshita, Bhavprkasha & Yogaratnaker.
Hundreds of therapeutic recipes are described in Ayurvedic classics for management of parinamashoola, Dhatrilauha is among such a formulae and contains three important ingredients, i.e. Amalaki, Yasthimadhu and lauha bhasma. Amalaki is a very popular drug and having wide range of actions., But in this regard, its ulcer healing, mucoprotective and enhance the effect of lauha are worth to be noted. Yasthimadhu (Liquorice) is also an effective ingredient, which has several actions, Anticholinergic, cytoprotective, ulcer healing are important to quote, lauha Bhasma has quality of Ramayana and also having pacifying effect of pitta and kappa Dhatrilauha is such a unique compound, which possess all such ingredients, by realizing all these unique qualities, Dhatrilauha is such a unique compound, which possess all such ingre3dients. B realizing all these unique qualities Dhatrilauha was taken for clinical evaluation under present study.
Regarding the various observation, incidence of Age was most common in third and fourth decades in both the groups. This can be due predominance of pitta. Observation of sex incidence, Non ulcer dyspepsia is more common in female cases (59.09%) tan males (40.91%) and peptic ulcer cases, ratio is equally distributed, stud of dehaprakriti showed maximum number of cases from vata-Paittika constitution in peptic ulcer an Non -ulcer dyspepsia both.
Response of treatment was assessed in terms of clinical, radiological and endoscopic improvement, clinical improvement was calculated statistically and by reduction of mean difference of symptoms score (Table  VII) Significant to highly significant improvement was found in symptom like pain in abdomen, acid eructation, vomiting, flatulence, heart burn and constipation etc, in all the groups of trial and control statistically.
B this results of certain symptoms was not significant (p >0.05), more in control group tan trial. If ma be due to less number of cases in peptic ulcer and non ulcer dyspepsia of control group.
It is found that trial drug (Dhatrilauha) was good to excellent response in almost all of the symptoms of peptic ulcer and non ulcer dyspepsia. And control drug (Ranitidine) also showed similar results, but comparatively it was batter in some symptoms. Total clinical response was also calculated in each patient and then percentage of reduction was calculated and it is shown in table No VIII.
Radiological and endoscopic improvement was also assessed in positive cases of peptic pages 3 -18 ulcer by repeat examination, Radiologically, there was mixed response from partial to good healing, it ma be due to tat, it requires long term treatment and further study., in repeat endoscopic examination, there was significant improvement in trial group and marked to good healing in cases of control group.
Conclusion
It can be concluded that, the present study proved the efficacy of Dhatri-lauha in management of parinamashoola (peptic Ulcer and Non Ulcer Dyspepsia). The mode of its action may be cytoprotective, antisecretary, increases the mucosal resistance and prokinetic action etc.
